Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…